We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+15.5%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$11.9B
AUM Growth
+$4.1B
Cap. Flow
+$2.63B
Cap. Flow %
22.08%
Top 10 Hldgs %
28.21%
Holding
929
New
318
Increased
304
Reduced
85
Closed
35

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$148M
2
NVDA icon
NVIDIA
NVDA
+$140M
3
AAPL icon
Apple
AAPL
+$123M
4
ABT icon
Abbott
ABT
+$96.6M
5
INTU icon
Intuit
INTU
+$85M

Top Sells

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$65.2M
2
UNH icon
UnitedHealth
UNH
+$35.5M
3
RUN icon
Sunrun
RUN
+$24.8M
4
CRM icon
Salesforce
CRM
+$16.7M
5
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 35.45%
2 Financials 13.4%
3 Healthcare 12.82%
4 Communication Services 10.08%
5 Consumer Discretionary 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DKS icon
576
Dick's Sporting Goods
DKS
$17.5B
$507K ﹤0.01%
+2,500
New +$463K
PEG icon
577
Public Service Enterprise Group
PEG
$38.2B
$499K ﹤0.01%
+5,971
New +$482K
CRVL icon
578
CorVel
CRVL
$3.06B
$497K ﹤0.01%
4,800
LGND icon
579
Ligand Pharmaceuticals
LGND
$5.76B
$491K ﹤0.01%
4,300
ZBRA icon
580
Zebra Technologies
ZBRA
$14B
$483K ﹤0.01%
+1,562
New +$424K
EYPT icon
581
EyePoint Inc
EYPT
$1.03B
$482K ﹤0.01%
50,000
EXPD icon
582
Expeditors International
EXPD
$22B
$477K ﹤0.01%
+4,200
New +$470K
VCYT icon
583
Veracyte
VCYT
$3.7B
$465K ﹤0.01%
17,000
TYL icon
584
Tyler Technologies
TYL
$12.7B
$465K ﹤0.01%
+800
New +$453K
NSC icon
585
Norfolk Southern
NSC
$75.4B
$453K ﹤0.01%
+1,770
New +$417K
AUTL
586
Autolus Therapeutics
AUTL
$397M
$450K ﹤0.01%
195,000
ACT icon
587
Enact Holdings
ACT
$6.61B
$438K ﹤0.01%
11,900
CWAN
588
DELISTED
Clearwater Analytics
CWAN
$437K ﹤0.01%
+19,528
New +$449K
MOS icon
589
The Mosaic Company
MOS
$7.03B
$437K ﹤0.01%
+12,417
New +$398K
TGT icon
590
Target
TGT
$65.6B
$433K ﹤0.01%
4,255
-18,896
-82% -$1.81M
TECK icon
591
Teck Resources
TECK
$29.6B
$431K ﹤0.01%
+5,682
New +$205K
ADPT icon
592
Adaptive Biotechnologies
ADPT
$3.59B
$421K ﹤0.01%
35,700
KHC icon
593
Kraft Heinz
KHC
$30.7B
$420K ﹤0.01%
16,323
+16,048
+5,836% +$445K
HRMY icon
594
Harmony Biosciences
HRMY
$2.04B
$419K ﹤0.01%
13,100
EPAM icon
595
EPAM Systems
EPAM
$5.51B
$419K ﹤0.01%
+2,400
New +$401K
CSL icon
596
Carlisle Companies
CSL
$14.3B
$415K ﹤0.01%
+1,100
New +$408K
IBRX icon
597
ImmunityBio
IBRX
$7.51B
$413K ﹤0.01%
153,000
CC icon
598
Chemours
CC
$2.5B
$412K ﹤0.01%
35,142
LH icon
599
Labcorp
LH
$25B
$411K ﹤0.01%
1,600
-859
-35% -$209K
DAL icon
600
Delta Air Lines
DAL
$57.5B
$409K ﹤0.01%
+8,352
New +$383K

Similar funds

Erste Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Erste Asset Management held 929 positions worth $11.9B, up 53% from $7.79B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Erste Asset Management deployed $2.63B of net new capital in Q2 2025, opening 318 new positions and adding to 304 existing holdings. Its largest new stake was Tesla: 123,645 shares worth $40M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Arch Capital, an estimated $65.2M trimmed.

  • Erste Asset Management's largest Q2 2025 buy was Tesla: 123,645 shares worth $40M.
  • Erste Asset Management added most to Microsoft in Q2 2025, an estimated $148M increase.
  • Erste Asset Management's biggest Q2 2025 reduction was Arch Capital, cutting an estimated $65.2M.
  • Erste Asset Management fully exited Teradyne in Q2 2025, selling an estimated $8.7M.
  • Erste Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q2 2025.
  • Erste Asset Management opened 318 new positions and closed 35 in Q2 2025.
  • Erste Asset Management's portfolio value rose 53% quarter-over-quarter to $11.9B.

Based on Erste Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.